LADENBURG THALMANN FINANCIAL SERVICES INC. - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 332 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 2.08 and the average weighting 0.2%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$232,000
+116.8%
2,214
+105.6%
0.00%0.0%
Q3 2019$107,000
+12.6%
1,077
+31.3%
0.00%0.0%
Q2 2019$95,000
+13.1%
820
+23.5%
0.00%0.0%
Q1 2019$84,0000.0%664
+6.1%
0.00%0.0%
Q4 2018$84,000
+44.8%
626
+199.5%
0.00%
Q3 2018$58,000
-26.6%
209
-56.6%
0.00%
-100.0%
Q2 2018$79,0000.0%4820.0%0.00%0.0%
Q1 2018$79,000
+17.9%
482
-0.2%
0.00%0.0%
Q4 2017$67,000
+17.5%
483
+16.1%
0.00%0.0%
Q3 2017$57,000
+1.8%
416
-9.2%
0.00%0.0%
Q2 2017$56,000
+5.7%
458
-7.8%
0.00%0.0%
Q1 2017$53,000
+3.9%
497
+1.2%
0.00%0.0%
Q4 2016$51,000
+21.4%
491
+21.8%
0.00%0.0%
Q3 2016$42,000
-66.4%
403
-61.1%
0.00%
-50.0%
Q2 2016$125,000
+135.8%
1,036
+111.0%
0.00%
+100.0%
Q1 2016$53,000
-36.9%
491
-36.4%
0.00%
-50.0%
Q4 2015$84,000
-77.5%
772
-82.4%
0.00%
-75.0%
Q3 2015$374,000
+27.6%
4,375
+50.9%
0.01%
+60.0%
Q2 2015$293,000
+713.9%
2,899
+519.4%
0.01%
+400.0%
Q1 2015$36,000
+100.0%
468
+35.3%
0.00%
Q4 2014$18,000
-47.1%
346
-51.8%
0.00%
-100.0%
Q3 2014$34,000
+3300.0%
718
+3888.9%
0.00%
Q2 2014$1,000
-90.9%
18
-91.0%
0.00%
Q4 2013$11,0002000.00%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
KNOTT DAVID M 353,041$36,819,00014.92%
CARDINAL CAPITAL MANAGEMENT LLC /CT 919,994$95,946,0002.93%
Elk Creek Partners, LLC 236,862$24,702,0002.84%
Conestoga Capital Advisors, LLC 619,653$64,624,0001.56%
WOODSTOCK CORP 71,489$7,456,0001.21%
Summit Creek Advisors LLC 70,962$7,401,0001.16%
FALCON POINT CAPITAL, LLC 8,115$846,0001.08%
RICE HALL JAMES & ASSOCIATES, LLC 302,503$31,548,0001.07%
Stephens Investment Management Group LLC 508,100$52,990,0001.00%
Tygh Capital Management, Inc. 55,672$5,806,0000.96%
View complete list of LIGAND PHARMACEUTICALS INC shareholders